TMED vs. XLVI
TMED (T. Rowe Price Health Care ETF) and XLVI (State Street Health Care Select Sector SPDR Premium Income ETF) are both exchange-traded funds - TMED is a Health & Biotech Equities fund managed by T. Rowe Price, while XLVI is a Derivative Income fund actively managed by State Street. Their correlation of 0.85 suggests significant overlap in exposure. TMED charges 0.44%/yr vs 0.35%/yr for XLVI.
Performance
TMED vs. XLVI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TMED achieves a 2.81% return, which is significantly higher than XLVI's -1.33% return.
TMED
- 1D
- -2.33%
- 1M
- 1.95%
- YTD
- 2.81%
- 6M
- 4.16%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
XLVI
- 1D
- -0.73%
- 1M
- 1.42%
- YTD
- -1.33%
- 6M
- 0.46%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
TMED vs. XLVI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
TMED T. Rowe Price Health Care ETF | 2.81% | 21.62% |
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | -1.33% | 12.79% |
Correlation
The correlation between TMED and XLVI is 0.85, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jul 31, 2025 | 0.85 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TMED vs. XLVI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| TMED | XLVI | Difference | |
|---|---|---|---|
Sharpe Ratio (All Time)Calculated using the full available price history | 1.29 | 1.25 | +0.04 |
Drawdowns
TMED vs. XLVI - Drawdown Comparison
The maximum TMED drawdown since its inception was -11.11%, which is greater than XLVI's maximum drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for TMED and XLVI.
Loading charts...
Drawdown Indicators
| TMED | XLVI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -11.11% | -8.14% | -2.97% |
Current DrawdownCurrent decline from peak | -3.75% | -4.66% | +0.91% |
Average DrawdownAverage peak-to-trough decline | -2.59% | -1.94% | -0.65% |
Volatility
TMED vs. XLVI - Volatility Comparison
Loading charts...
Volatility by Period
| TMED | XLVI | Difference | |
|---|---|---|---|
Volatility (1Y)Calculated over the trailing 1-year period | 18.05% | 10.94% | +7.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.05% | 10.94% | +7.11% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.05% | 10.94% | +7.11% |
TMED vs. XLVI - Expense Ratio Comparison
TMED has a 0.44% expense ratio, which is higher than XLVI's 0.35% expense ratio.
Dividends
TMED vs. XLVI - Dividend Comparison
TMED's dividend yield for the trailing twelve months is around 0.53%, less than XLVI's 11.61% yield.
| Position | TTM | 2025 |
|---|---|---|
TMED T. Rowe Price Health Care ETF | 0.53% | 0.54% |
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | 11.61% | 5.73% |
Frequently Asked Questions
TMED and XLVI have a correlation of 0.85, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XLVI is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XLVI is cheaper with a 0.35% expense ratio, compared with 0.44% for TMED.
XLVI has the higher dividend yield at 11.61%, compared with 0.53% for TMED.
TMED is categorized as Health & Biotech Equities, while XLVI is Derivative Income. They also come from different issuers: T. Rowe Price and State Street. Their fees differ too: 0.44% for TMED and 0.35% for XLVI.
Find the right allocation for TMED and XLVI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer